LÖSLICHKEITSOPTIMIERUNG VON IMMUNBINDERN

Patent europeic · EP2307455 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2307455
Numer da la dumonda
EP09768694
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-06-2009
Publitgà
13-04-2011
Concedì
22-03-2017
Stritgà
01-02-2023
Motiv
Revocà en la procedura d’opposiziun
Classas IPC
C07K 16/22 (2006.01)
C07K 16/24 (2006.01)
Prioritad
US 75692 P 25.06.2008
Dumonda PCT
PCT/CH2009/000221 25.06.2009
Publicaziun PCT
WO2009/155725 30.12.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  2. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  3. 22-03-2017

    Concedì

    Published in Swissreg on 22.03.2017

  4. 22-03-2017

    Curregì

    Published in Swissreg on 22.03.2017

Partidas

Possessur

ESBATech, an Alcon Biomedical Research Unit LLC

Wagistrasse 21, 8952 Schlieren

Inventur

BORRAS, Leonardo

CH-8952 Schlieren

URECH, David

8634 Hombrechtikon

Licenziat

Cell Medica Switzerland AG in Liquidation

Delenex Therapeutics AG

Wagistrasse 27, 8952 Schlieren

Stizzada dal register

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.